Additionally, outbreaks occurred on five campuses between March 2013 and February 2016, resulting in two deaths, along with a limb amputation in one victim and neurological issues in others.
Additionally, outbreak-affected countries with heavily burdened public health systems may have limited resources to invest in departure screening, while limited preparation, awareness or focus may lower efficacy during arrival screening in countries outside the epidemic region.
Additionally, outbreaks have been described from South Africa, Australia, China and India [ 7– 10].
Additionally, outbreaks of vaccine-preventable diseases continue to occur due to low population immunity and a lack of security in some places continues to pose problems.
Additionally, outbreaks of human and animal diseases, like cholera, measles or anthrax, could be monitored closely, enabling control measures to be quickly implemented.
Additionally, outbreaks where the primary mode was unknown had lower log-transformed mean numbers of primary cases (p < 0.005) and higher median numbers of secondary cases (p < 0.01) than outbreaks with all other (known) primary modes.
Additionally, outbreaks and single reports of VIM- or IMP-type producers have been reported in several countries of Mediterranean area, such as France [ 50, 51], Spain [ 33], Morocco [ 52], Egypt [ 53, 54], Algeria [ 55], and Tunisia [ 56].
Additionally, outbreaks of infectious diseases such as typhus, dengue and pneumonia have been documented, possibly due to the high-density living conditions and occasionally less than satisfactory sanitary living conditions [ 8- 10].
Additionally, pest outbreak has been shown to be interwoven with land-use intensity.
Additionally, 3 outbreak strains (AG1, AG2, AG3) from Agronomica and 1 strain each from chickens (MG4) and pigs (P3) were found in this group that otherwise contained a majority of ocular toxoplasmosis isolates from the Erechim region.
Additionally, an outbreak of cholera in July 2012 in Granma Province, Cuba attributed to the same serotype found in Haiti and the Dominican Republic: V. cholera, serogroup O1, serotype Ogawa, Biotype El Tor indicates potential spread from Hispaniola (27). Figure 2 depicts CDC's international responses to outbreaks of cholera from January 2007 to August 2012.
